BONE BIOMARKERS ARE USEFUL IN MONITORING MYELOMA BONE DISEASE AND AS EARLY PREDICTOR FOR RELAPSE DISEASE IN MULTIPLE MYELOMA

被引：0
|
作者：
Ting, K. [1 ,2 ]
Hameed, A. [1 ,2 ]
Brady, J. [1 ]
Carke, C. [2 ]
Justine, M. [2 ]
Dowling, P. [2 ]
Clynes, M. [2 ]
O'Gorman, P. [1 ,2 ]
机构：
[1] Mater Misericordiae Univ Hosp, Haematol, Dublin, Ireland
[2] Natl Inst Cellular Biotechnol, Dublin, Ireland
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P798
引用
收藏
页码：334 / 335
页数：2
相关论文
共 50 条
  • [31] Pathogenesis and treatment of multiple myeloma bone disease
    Hiasa, Masahiro
    Harada, Takeshi
    Tanaka, Eiji
    Abe, Masahiro
    JAPANESE DENTAL SCIENCE REVIEW, 2021, 57 : 164 - 173
  • [32] Bone Disease mimicking multiple myeloma in an octogenarian
    Kechaou, Ines
    Boukhris, Imene
    PAN AFRICAN MEDICAL JOURNAL, 2015, 22
  • [33] Role of osteocytes in multiple myeloma bone disease
    Delgado-Calle, Jesus
    Bellido, Teresita
    Roodman, G. David
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2014, 8 (04) : 407 - 413
  • [34] Myeloma-bone interaction for the development of myeloma bone disease
    Matsumoto, T
    Kido, S
    Inoue, D
    Oshima, T
    Abe, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1566 - 1566
  • [35] Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers
    褚彬
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (03) : 184 - 185
  • [36] The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease
    Ryan T. Bishop
    Anna K. Miller
    Matthew Froid
    Niveditha Nerlakanti
    Tao Li
    Jeremy S. Frieling
    Mostafa M. Nasr
    Karl J. Nyman
    Praneeth R. Sudalagunta
    Rafael R. Canevarolo
    Ariosto Siqueira Silva
    Kenneth H. Shain
    Conor C. Lynch
    David Basanta
    Nature Communications, 15
  • [37] The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease
    Bishop, Ryan T.
    Miller, Anna K.
    Froid, Matthew
    Nerlakanti, Niveditha
    Li, Tao
    Frieling, Jeremy S.
    Nasr, Mostafa M.
    Nyman, Karl J.
    Sudalagunta, Praneeth R.
    Canevarolo, Rafael R.
    Silva, Ariosto Siqueira
    Shain, Kenneth H.
    Lynch, Conor C.
    Basanta, David
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [38] Pathophysiology of myeloma bone disease
    Esteve, Flavia R.
    Roodman, G. David
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 613 - 624
  • [39] Myeloma bone disease.
    Mundy, GR
    Oyajobi, B
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 819 - 819
  • [40] Pathophysiology of myeloma bone disease
    Croucher, P. I.
    Heath, D.
    Chantry, A.
    Lawson, M.
    Buckle, C.
    Vanderkerken, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 17 - 18
12345